Literature DB >> 8192549

Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia.

R Heaton1, J S Paulsen, L A McAdams, J Kuck, S Zisook, D Braff, J Harris, D V Jeste.   

Abstract

BACKGROUND: We sought to determine whether neuropsychological impairment in schizophrenia is related to current age, age at onset, or duration of illness, and whether the pattern of such impairment can be distinguished from that caused by progressive dementias of Alzheimer's type. We administered a comprehensive neuropsychological test battery to a normal control group (n = 38), a group of ambulatory patients with Alzheimer's disease (n = 42), and three ambulatory schizophrenic groups: early onset-young (n = 85), early onset-old (n = 35), and late onset (n = 22). Tests were grouped and analyzed according to eight major ability areas, and published procedures were used to remove the expected effects of normal aging.
RESULTS: The three schizophrenic groups were found to be neuropsychologically similar to one another and different from normal controls and patients with Alzheimer's disease. There were no significant differences among the schizophrenic groups in level or pattern of neuropsychological functioning. Patients with Alzheimer's disease demonstrated less efficient learning and particularly more rapid forgetting than did the other groups.
CONCLUSIONS: These findings suggest that neuropsychological impairment in schizophrenia is unrelated to current age, age at onset, or duration of illness. The study further suggests that the encephalopathy associated with schizophrenia is essentially nonprogressive and produces a pattern of deficits that is different from that seen in progressive cortical dementias.

Entities:  

Mesh:

Year:  1994        PMID: 8192549     DOI: 10.1001/archpsyc.1994.03950060033003

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  61 in total

1.  Cognition, schizophrenia, and the atypical antipsychotic drugs.

Authors:  H Y Meltzer; S Park; R Kessler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Antipsychotic treatment for late-life schizophrenia.

Authors:  Jeremy A Sable; Dilip V Jeste
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

3.  Predictors of Attrition in a Cohort Study of HIV Infection and Methamphetamine Dependence.

Authors:  J Cattie; M J Marquine; K A Bolden; L C Obermeit; E E Morgan; D R Franklin; A Umlauf; J M Beck; J H Atkinson; I Grant; S P Woods
Journal:  J Subst Use       Date:  2015-02-03

4.  Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.

Authors:  Colin A Depp; David J Moore; David Sitzer; Barton W Palmer; Lisa T Eyler; Scott Roesch; Barry D Lebowitz; Dilip V Jeste
Journal:  J Affect Disord       Date:  2007-01-16       Impact factor: 4.839

5.  Subjective and objective quality of life in schizophrenia.

Authors:  Jenille M Narvaez; Elizabeth W Twamley; Christine L McKibbin; Robert K Heaton; Thomas L Patterson
Journal:  Schizophr Res       Date:  2007-10-04       Impact factor: 4.939

Review 6.  Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function.

Authors:  William S Stone; Larry J Seidman
Journal:  Schizophr Bull       Date:  2007-05-15       Impact factor: 9.306

7.  Enhancement of executive functioning skills: an additional tier in the treatment of schizophrenia.

Authors:  Deana B Davalos; Mack Green; Daniel Rial
Journal:  Community Ment Health J       Date:  2002-10

8.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

9.  Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.

Authors:  V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

Review 10.  Is schizophrenia a syndrome of accelerated aging?

Authors:  Brian Kirkpatrick; Erick Messias; Philip D Harvey; Emilio Fernandez-Egea; Christopher R Bowie
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.